0001181431-14-004414.txt : 20140130
0001181431-14-004414.hdr.sgml : 20140130
20140130164306
ACCESSION NUMBER: 0001181431-14-004414
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20140129
FILED AS OF DATE: 20140130
DATE AS OF CHANGE: 20140130
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: AVEO PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0001325879
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 000000000
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 650 E. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
BUSINESS PHONE: 6172995000
MAIL ADDRESS:
STREET 1: 650 E. KENDALL STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02142
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Slichenmyer William
CENTRAL INDEX KEY: 0001486428
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-34655
FILM NUMBER: 14561268
MAIL ADDRESS:
STREET 1: AVEO PHARMACEUTICALS, INC.
STREET 2: 75 SIDNEY STREET
CITY: CAMBRIDGE
STATE: MA
ZIP: 02139
4
1
rrd400945.xml
SLICHENMYER FORM 4
X0306
4
2014-01-29
0
0001325879
AVEO PHARMACEUTICALS INC
AVEO
0001486428
Slichenmyer William
C/O AVEO PHARMACEUTICALS, INC.
650 E. KENDALL STREET
CAMBRIDGE
MA
02142
0
1
0
0
Chief Medical Officer
Common Stock
2014-01-29
4
D
0
3200
0
D
40543
D
Common Stock
2014-01-30
4
S
0
5430
1.6435
D
35113
D
Stock Option (right-to-buy)
1.77
2014-01-29
4
A
0
75000
0
A
2024-01-29
Common Stock
75000
75000
D
Shares underlying such disposition to the issuer were forfeited by the reporting person pursuant to the terms of an award of restricted stock granted to the reporting person on June 26, 2013 in connection with the determination of the issuer's Compensation Committee that certain specified strategic performance objectives were not met.
The sale reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2013, which was implemented to cover taxable events related to the partial vesting of certain restricted stock.
The price reported in this Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $1.61 to $1.69, inclusive. The reporting person undertakes to provide AVEO Pharmaceuticals, Inc., any security holder of AVEO Pharmaceuticals, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the ranges set forth in this footnote.
This option vests in equal monthly installments from January 1, 2014 through January 1, 2018.
/s/Joseph D. Vittigio, Esq., attorney-in-fact
2014-01-30